Diphtheria Vaccine Market By Product ( DTaP, DT, Td, Tdap ), By Application ( For infants and children below 7 years, For adolescents and adults ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Apr, 2018
  • Category: Healthcare
  • Pages: 162
Diphtheria Vaccine Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

Diphtheria is an infection caused by the bacterium Corynebacterium diphtheriae which can lead to severe problems such as myocarditis, inflammation of nerves, kidney problems, and bleeding problems, caused due to low levels of platelets. Diphtheria vaccine is a vaccine which blocks the expansion of Corynebacterium diphtheriae, and is highly efficient in killing it. The biggest advantage of this vaccine is that the vaccine is free from side effects, and very safe to be used for even pregnant woman and low-immunity individuals. Diphtheria can cause serious complications such as paralysis, pneumonia, and lung failure. It can also be fatal, especially for the children falling under the age group of 1 in 5 years. The diphtheria vaccine is delivered in the form of various combinations for specific diseases such as tetanus, hepatitis B and many others. As per an estimate, about 86% of the world population was vaccinated as of 2016. In developed countries such as United States, diphtheria is a rare diseases now, but people, especially young children are still prone to the very disease. Persistent initiatives taken by various governments and increasing awareness regarding diphtheria and its symptoms, among developing and under-developed countries such as India, Nigeria and many others, are expected to put forward some lucrative opportunities for the diphtheria vaccine market in the near future. The report provides detailed qualitative and quantitative analysis of the Diphtheria Vaccine Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Diphtheria Vaccine Market Segmentation

By Product • DTaP • DT • Td • Tdap By Application • For infants and children below 7 years • For adolescents and adults By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. DIPHTHERIA VACCINE MARKET OVERVIEW 2.1. DIPHTHERIA VACCINE MARKET INTRODUCTION 2.2. GLOBAL DIPHTHERIA VACCINE MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Diphtheria Vaccine Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL DIPHTHERIA VACCINE MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Diphtheria Vaccine Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL DIPHTHERIA VACCINE MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Diphtheria Vaccine Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL DIPHTHERIA VACCINE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Diphtheria Vaccine Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL DIPHTHERIA VACCINE MARKET PRICE TREND, 2017-2025 2.6.1. Global Diphtheria Vaccine Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL DIPHTHERIA VACCINE MARKET BY PRODUCT, 2017-2025 3.1. DT 3.2. DTAP 3.3. TDAP 3.4. TD 3.5. GLOBAL DIPHTHERIA VACCINE MARKET REVENUE BY PRODUCT, 2017-2025 3.5.1. Global Diphtheria Vaccine Market Revenue (Million USD) and Share (%) By Product, 2017-2025 3.5.2. DT Market Revenue and Growth Rate, 2017-2025 3.5.3. DTaP Market Revenue and Growth Rate, 2017-2025 3.5.4. Tdap Market Revenue and Growth Rate, 2017-2025 3.6. GLOBAL DIPHTHERIA VACCINE MARKET PRODUCTION BY PRODUCT, 2017-2025 3.6.1. Global Diphtheria Vaccine Market Production (Volume) and Share (%) By Product, 2017-2025 3.6.2. DT Market Production and Growth Rate, 2017-2025 3.6.3. DTaP Market Production and Growth Rate, 2017-2025 3.6.4. Tdap Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other product segment. CHAPTER 4. GLOBAL DIPHTHERIA VACCINE MARKET BY APPLICATION, 2017-2025 4.1. FOR INFANTS AND CHILDREN BELOW 7 YEARS 4.2. FOR ADOLESCENTS AND ADULTS 4.3. GLOBAL DIPHTHERIA VACCINE MARKET REVENUE BY APPLICATION, 2017-2025 4.3.1. Global Diphtheria Vaccine Market Revenue (Million USD) and Share (%) By Application, 2017-2025 4.3.2. For infants and children below 7 years Market Revenue and Growth Rate, 2017-2025 4.3.3. For adolescents and adults Market Revenue and Growth Rate, 2017-2025 4.4. GLOBAL DIPHTHERIA VACCINE MARKET CONSUMPTION BY APPLICATION, 2017-2025 4.4.1. Global Diphtheria Vaccine Market Consumption (Volume) and share (%) By Application, 2017-2025 4.4.2. For infants and children below 7 years Market Consumption and Growth Rate, 2017-2025 4.4.3. For adolescents and adults Market Consumption and Growth Rate, 2017-2025 CHAPTER 5. GLOBAL DIPHTHERIA VACCINE MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL DIPHTHERIA VACCINE MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Diphtheria Vaccine Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL DIPHTHERIA VACCINE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL DIPHTHERIA VACCINE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Diphtheria Vaccine Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Diphtheria Vaccine Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL DIPHTHERIA VACCINE MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL DIPHTHERIA VACCINE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Diphtheria Vaccine Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL DIPHTHERIA VACCINE REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Diphtheria Vaccine Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. DIPHTHERIA VACCINE MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Diphtheria Vaccine Market Share (%) of Top 3 Manufacturers 8.3.2. Diphtheria Vaccine Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL DIPHTHERIA VACCINE MANUFACTURERS ANALYSIS 9.1. SANOFI PASTEUR 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Diphtheria Vaccine Product Details 9.1.4. Sanofi Pasteur Diphtheria Vaccine Production, Revenue and Gross Margin 9.2. MERCK 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Diphtheria Vaccine Product Details 9.2.4. Merck Diphtheria Vaccine Production, Revenue and Gross Margin 9.3. BEIJING TIANTAN BIOLOGICAL PRODUCTS 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Diphtheria Vaccine Product Details 9.3.4. Beijing Tiantan Biological Products Diphtheria Vaccine Production, Revenue and Gross Margin 9.4. SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Diphtheria Vaccine Product Details 9.4.4. Shanghai Institute of Biological Products Diphtheria Vaccine Production, Revenue and Gross Margin 9.5. WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Diphtheria Vaccine Product Details 9.5.4. Wuhan Institute of Biological Products Diphtheria Vaccine Production, Revenue and Gross Margin 9.6. CHENGDU INSTITUTE OF BIOLOGICAL PRODUCTS 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Diphtheria Vaccine Product Details 9.6.4. Chengdu Institute of Biological Products Diphtheria Vaccine Production, Revenue and Gross Margin 9.7. CHANGCHUN CHANGSHENG LIFE SCIENCES 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Diphtheria Vaccine Product Details 9.7.4. Changchun Changsheng Life Sciences Diphtheria Vaccine Production, Revenue and Gross Margin 9.8. GLAXOSMITHKLINE 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Diphtheria Vaccine Product Details 9.8.4. GlaxoSmithKline Diphtheria Vaccine Production, Revenue and Gross Margin 9.9. WYETH PFIZER 9.9.1. Business Overview 9.9.2. Company Basic Information 9.9.3. Diphtheria Vaccine Product Details 9.9.4. Wyeth Pfizer Diphtheria Vaccine Production, Revenue and Gross Margin 9.10. NOVARTIS 9.10.1. Business Overview 9.10.2. Company Basic Information 9.10.3. Diphtheria Vaccine Product Details 9.10.4. Novartis Diphtheria Vaccine Production, Revenue and Gross Margin CHAPTER 10. DIPHTHERIA VACCINE MARKET VALUE CHAIN ANALYSIS 10.1. DIPHTHERIA VACCINE INDUSTRIAL CHAIN ANALYSIS 10.2. DIPHTHERIA VACCINE KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4

• Sanofi Pasteur
• Merck
• Beijing Tiantan Biological Products
• Shanghai Institute of Biological Products
• Wuhan Institute of Biological Products
• Chengdu Institute of Biological Products
• Changchun Changsheng Life Sciences
• GlaxoSmithKline
• Wyeth Pfizer
• Novartis

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS